Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesRohina Joshi, Anushka Patel, Stephen MacMahon et al.|New England Journal of Medicine|2008Cited by 7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyVlado Perkovic, Kenneth W. Mahaffey, Rajiv Agarwal et al.|New England Journal of Medicine|2019Cited by 6k
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysisBrendon L. Neuen, Meg Jardine, T. Kue Young et al.|The Lancet Diabetes & Endocrinology|2019Cited by 870
Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart DiseaseClara K Chow, Aravinda Thiagalingam, Julie Redfern et al.|JAMA|2015Cited by 717